Literature DB >> 14983946

The story of the European Randomized Study of Screening for Prostate Cancer.

F H Schröder1, L J Denis, M Roobol, V Nelen, A Auvinen, T Tammela, A Villers, X Rebillard, S Ciatto, M Zappa, A Berenguer, A Paez, J Hugosson, P Lodding, F Recker, M Kwiatkowski, W J Kirkels.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 14983946     DOI： 10.1111/j.1464-410x.2003.04389.x

Source DB:  PubMed          Journal:  BJU Int        ISSN： 1464-4096            Impact factor:   5.588


× No keyword cloud information.
  25 in total

1.  Screening for prostate cancer in younger men.

Authors:  Dragan Ilic; Sally Green
Journal:  BMJ       Date:  2007-11-15

2.  Screening for prostate cancer: a controversy or fact.

Authors:  S Stavridis; S Saidi; Lj Lekovski; S Dohcev; G Spasovski
Journal:  Hippokratia       Date:  2010-07       Impact factor: 0.471

3.  Quality-of-life effects of prostate-specific antigen screening.

Authors:  Eveline A M Heijnsdijk; Elisabeth M Wever; Anssi Auvinen; Jonas Hugosson; Stefano Ciatto; Vera Nelen; Maciej Kwiatkowski; Arnauld Villers; Alvaro Páez; Sue M Moss; Marco Zappa; Teuvo L J Tammela; Tuukka Mäkinen; Sigrid Carlsson; Ida J Korfage; Marie-Louise Essink-Bot; Suzie J Otto; Gerrit Draisma; Chris H Bangma; Monique J Roobol; Fritz H Schröder; Harry J de Koning
Journal:  N Engl J Med       Date:  2012-08-16       Impact factor: 91.245

4.  Complications of initial prostate biopsy in a European randomized screening trial.

Authors:  Suzanne van den Heuvel; Stacy Loeb; Xiaoye Zhu; Paul Cms Verhagen; Fritz H Schröder; Chris H Bangma; Monique J Roobol
Journal:  Am J Clin Exp Urol       Date:  2013-12-25

5.  Efficacy versus effectiveness study design within the European screening trial for prostate cancer: consequences for cancer incidence, overall mortality and cancer-specific mortality.

Authors:  Xiaoye Zhu; Pim J van Leeuwen; Erik Holmberg; Meelan Bul; Sigrid Carlsson; Fritz H Schröder; Monique J Roobol; Jonas Hugosson
Journal:  J Med Screen       Date:  2012-09       Impact factor: 2.136

6.  [Status of care for prostate cancer in 2008].

Authors:  B Arndt; M Kwiatkowski; F Recker
Journal:  Urologe A       Date:  2008-08       Impact factor: 0.639

Review 7.  Risk stratification in prostate cancer screening.

Authors:  Monique J Roobol; Sigrid V Carlsson
Journal:  Nat Rev Urol       Date:  2012-12-18       Impact factor: 14.432

8.  A standardised study to compare prostate cancer targeting efficacy of five radiolabelled bombesin analogues.

Authors:  Rogier P J Schroeder; Cristina Müller; Suzanne Reneman; Marleen L Melis; Wout A P Breeman; Erik de Blois; Chris H Bangma; Eric P Krenning; Wytske M van Weerden; Marion de Jong
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-02-25       Impact factor: 9.236

9.  Decision analysis for the evaluation of diagnostic tests, prediction models and molecular markers.

Authors:  Andrew J Vickers
Journal:  Am Stat       Date:  2008       Impact factor: 8.710

Review 10.  What do the screening trials really tell us and where do we go from here?

Authors:  Ruth D Etzioni; Ian M Thompson
Journal:  Urol Clin North Am       Date:  2014-02-19       Impact factor: 2.241
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.